All In Biotech

Drug Trial Radar · NCT04333576

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Combined Oral Contraceptives in Premenopausal Women With Documented Endometriosis and Associated Moderate to Severe Pain

Last checked: Nov 19, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Aug 10, 2020

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Apr 3, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 49 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and mental health. This study will evaluate how well elagolix in combination with combined oral contraceptives (COC) works within the body and/or how safe it is compared to placebo (does not contain treatment drug). This study will assess the dysmenorrhea (painful periods) response in participants with endometriosis and associated pain. Elagolix is an approved drug for the management of moderate to severe pain associated with endometriosis. Participants are randomly put in 1 of 3 groups, called treatment arms. Each group receives a different treatment. There is a 1 in 3 chance that participants will be assigned to placebo. Adult female participants who still have periods with a diagnosis of endometriosis will be enrolled. Around 800 participants will be enrolled in the study at multiple sites in the United States, including Puerto Rico. Participants will receive oral elagolix or placebo tablets in combination with combined oral contraceptive (COC) or placebo capsules for 3 months. All the participants will receive elagolix tablets in combination with COC tablets from Month 4 through Month 18. There will be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the course of the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Conditions

  • Endometriosis

Interventions

  • ElagolixDrug

    Tablet:Oral

  • PlaceboDrug

    Tablet:Oral

  • Combined Oral ContraceptiveDrug

    Tablet:Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Responders Based on Dysmenorrhea (DYS) Pain ScaleTime frame: Month 3
  2. Number of Participants Experiencing Adverse Events (AEs)Time frame: Up to approximately 50 months

Locations

179 sites in 2 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group /ID# 217062

    Anniston, Alabama

  • ACCEL Research Sites /ID# 218044

    Birmingham, Alabama

  • Alabama Clinical Therapeutics /ID# 217166

    Birmingham, Alabama

  • Alabama Clinical Therapeutics /ID# 222301

    Birmingham, Alabama

  • University of Alabama at Birmingham - Women's and Infant's Center /ID# 224503

    Birmingham, Alabama

  • Trinity Research Group /ID# 246932

    Dothan, Alabama

  • Southern Women's Specialists PC /ID# 217143

    Fairhope, Alabama

  • Women's Health Alliance of Mobile /ID# 222591

    Mobile, Alabama

  • Mobile, OBGYN P.C. /ID# 217135

    Mobile, Alabama

  • North Valley Women's Care /ID# 217092

    Glendale, Arizona

  • MomDoc Womens Health Research /ID# 221661

    Phoenix, Arizona

  • Applied Research Center of Arkansas /ID# 248494

    Little Rock, Arkansas

  • Unity Health- Searcy Medical Center /ID# 217050

    Searcy, Arkansas

  • Diagnamics Inc. /ID# 225385

    Encinitas, California

  • Atella Clinical Research /ID# 224024

    La Palma, California

  • Valley Renal Medical Group Research /ID# 228614

    Northridge, California

  • Futura Research, Org /ID# 217361

    Norwalk, California

  • Northern California Research /ID# 217301

    Sacramento, California

  • A & B Clinical Research /ID# 224471

    San Diego, California

  • Advanced Clinical Research Center, LLC /ID# 248398

    San Diego, California

  • Rocky Mountain Internal Medicine - Aurora /ID# 245161

    Aurora, Colorado

  • Velocity Clinical Research - Denver /ID# 217297

    Denver, Colorado

  • Boeson Research - Grand Junction /ID# 248580

    Grand Junction, Colorado

  • Advanced Women's Health Institute /ID# 217150

    Greenwood Village, Colorado

  • Red Rocks OB/GYN /ID# 217103

    Lakewood, Colorado

  • Reproductive Assoc of Delaware /ID# 227764

    Newark, Delaware

  • Medstar Health Research Institute /ID# 244937

    Washington D.C., District of Columbia

  • James A. Simon, MD, PC /ID# 218116

    Washington D.C., District of Columbia

  • Topaz Clinical Research /ID# 218615

    Apopka, Florida

  • Ideal Clinical Research Inc. /ID# 218832

    Aventura, Florida

  • Helix Biomedics, LLC /ID# 218649

    Boynton Beach, Florida

  • Olympian Clinical Research /ID# 244426

    Clearwater, Florida

  • Women's Medical Research Group /ID# 218524

    Clearwater, Florida

  • Doral Medical Research, LLC /ID# 225146

    Doral, Florida

  • Universal Axon Clinical Research /ID# 248553

    Doral, Florida

  • KO Clinical Research, LLC /ID# 217173

    Fort Lauderdale, Florida

  • Alliance for Multispecialty Research (AMR) - Fort Myers /ID# 217061

    Fort Myers, Florida

  • Solutions Through Adv Rch /ID# 220973

    Jacksonville, Florida

  • Care Partners Clinical Research /ID# 217042

    Jacksonville, Florida

  • Vida Clinical Research /ID# 245325

    Kissimmee, Florida

Showing 40 of 179 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.